Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Liver Metastases From Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01285102
What this trial is testing

Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
Fox Chase Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT04126655
What this trial is testing

Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate

Who this might be right for
Metastatic Colorectal Cancer
Vastra Gotaland Region 30
Post-approval studies (Phase 4)Study completedNCT01695772
What this trial is testing

Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Study completedNCT00002997
What this trial is testing

Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Ended earlyNCT02738606
What this trial is testing

Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+5 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT05967143
What this trial is testing

Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Liver Metastases From Colorectal Cancer (mCRC)
Sirtex Medical 845
Early research (Phase 1)Not Yet RecruitingNCT06283134
What this trial is testing

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 60
Early research (Phase 1)Ended earlyNCT03029988
What this trial is testing

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Who this might be right for
Liver MetastasesColorectal Carcinoma
Navidea Biopharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT00002842
What this trial is testing

Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
City of Hope Medical Center 49
Large-scale testing (Phase 3)WithdrawnNCT01646554
What this trial is testing

Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Mutated Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Ended earlyNCT01508000
What this trial is testing

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Not applicableStudy completedNCT06779734
What this trial is testing

Radiomics of Colorectal Liver Metastases: Identification of New Prognostic Biomarkers.

Who this might be right for
Liver Metastases From Colorectal Cancer (mCRC)
Istituto Clinico Humanitas 400
Not applicableStudy completedNCT00724503
What this trial is testing

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaLiver Metastases
Sirtex Medical 530
Not applicableUnknownNCT04865471
What this trial is testing

Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy

Who this might be right for
Liver Metastases
Azienda Ospedaliera di Padova 18
Not applicableNot Yet RecruitingNCT07191548
What this trial is testing

International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverLiver AblationLiver Cancer, Adult
Angiodynamics, Inc. 50
Not applicableStudy completedNCT00499395
What this trial is testing

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT00997685
What this trial is testing

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Who this might be right for
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Guangdong Provincial People's Hospital 110
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Next Page